160 related articles for article (PubMed ID: 31413543)
1. Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate.
Lee HG; Park YS; Jeong JH; Kwon YB; Shin DH; Kim JY; Rhee YS; Park ES; Kim DW; Park CW
Drug Des Devel Ther; 2019; 13():2459-2474. PubMed ID: 31413543
[No Abstract] [Full Text] [Related]
2. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
Tiwari R; Gupta A; Joshi M; Tiwari G
PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
[TBL] [Abstract][Full Text] [Related]
3. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
4. Bilayer Tablet Dissolution Kinetics Based on a Degassing Cyclic Flow UV-Vis Spectroscopy with Chemometrics.
Otsuka Y; Ito A; Takahashi T; Matsumura S; Takeuchi M; Tanaka H
Chem Pharm Bull (Tokyo); 2019; 67(4):361-366. PubMed ID: 30930440
[TBL] [Abstract][Full Text] [Related]
5. Combined study of biphasic and zero-order release formulations with dissolution tests and ATR-FTIR spectroscopic imaging.
Wray P; Li J; Li LQ; Kazarian SG
J Pharm Sci; 2014 Jul; 103(7):1995-2004. PubMed ID: 24801351
[TBL] [Abstract][Full Text] [Related]
6. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.
Panda B; Subhadarsini R; Mallick S
Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690
[TBL] [Abstract][Full Text] [Related]
7. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
8. Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium.
Okunlola A
Front Pharmacol; 2014; 5():294. PubMed ID: 25628566
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
Loh ZC; Elkordy AA
Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
[TBL] [Abstract][Full Text] [Related]
10. Swellable and porous bilayer tablet for gastroretentive drug delivery: Preparation and in vitro-in vivo evaluation.
Hwang KM; Nguyen TT; Seok SH; Jo HI; Cho CH; Hwang KM; Kim JY; Park CW; Rhee YS; Park ES
Int J Pharm; 2019 Dec; 572():118783. PubMed ID: 31678393
[TBL] [Abstract][Full Text] [Related]
11. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study.
Owayez AS; Abd El-Ghany GM; Abu Hashim II
Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647
[TBL] [Abstract][Full Text] [Related]
12. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
Krishnaiah YS; Karthikeyan RS; Satyanarayana V
Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
[TBL] [Abstract][Full Text] [Related]
13. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs.
Dhiman N; Awasthi R; Jindal S; Khatri S; Dua K
Polim Med; 2016; 46(1):5-15. PubMed ID: 28397414
[TBL] [Abstract][Full Text] [Related]
14. Applications of Fourier transform infrared spectroscopic imaging to tablet dissolution and drug release.
Kazarian SG; Ewing AV
Expert Opin Drug Deliv; 2013 Sep; 10(9):1207-21. PubMed ID: 23682794
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Maltose-Induced Chemical Degradation at the Interface of Bilayer Tablets.
Matsuzaki N; Yamamoto Y; Murayama D; Katakawa Y; Mimura H; Kimura SI; Iwao Y; Itai S
Chem Pharm Bull (Tokyo); 2017; 65(5):478-486. PubMed ID: 28458369
[TBL] [Abstract][Full Text] [Related]
16. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
17. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Influence of Tablet Location Inside Dissolution Test Apparatus on Polymer Erosion and Drug Release of a Surface-Erodible Sustained-Release Tablet Using Computational Simulation Methods.
Lou H; Hageman MJ
AAPS PharmSciTech; 2021 Mar; 22(3):99. PubMed ID: 33709248
[TBL] [Abstract][Full Text] [Related]
19. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
20. Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin.
Oh JH; Eun Lee J; Jeong Kim Y; Oh TO; Han S; Jeon EK; Shin K; Kim DH; Hye Park C; Lee YJ
Drug Dev Ind Pharm; 2016; 42(2):340-9. PubMed ID: 26467296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
